Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management

Cancer Journal

Volumn 12, Issue 4, 2006, Pages 318-326

  Machi, Junji ^a,c   Oishi, Andrew J ^a   Sumida, Kenneth ^a   Sakamoto, Kazuhiro ^a   Furumoto, Nancy L ^a   Oishi, Robert H ^a   Kylstra, Jelle W ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b Rita Medical Systems   (United States)

^c NONE   (United States)

Author keywords

Colorectal cancer; Extrahepatic metastasis; First and second line management; Liver metastasis; Prognostic factors; Radiofrequency ablation

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

CANCER SURVIVAL; COLORECTAL CANCER; FOLLOW UP; HUMAN; LIVER METASTASIS; LONG TERM CARE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; UNIVARIATE ANALYSIS;

EID: 33747832153     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200607000-00011     Document Type: Review

References (34)

1. Solbiati L, Goldberg SN, Ierace T et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology 1997;205:367-373.
2. Jiao LR, Hansen PD, Havlik R et al. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg 1999;177:303-306.
3. Curley SA, Izzo F, Delrio P et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1-8.
4. Bilchik AJ, Rose DM, Allegra DP. Radiofrequency ablation: a minimally invasive technique with multiple applications. Cancer J Sci Am 1999;5:356-361.
5. Siperstein A, Garland A, Engle K et al. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol 2000;7:106-113.
6. Machi J, Uchida S, Sumida K et al. Ultrasound-guided radiofrequency thermal ablation of liver tumors: percutaneous, laparoscopic, and open surgical approaches. J Gastrointest Surg 2001;5:477-489.
7. Bowles BJ, Machi J, Limm WML et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001;136:864-869.
8. Parikh AA, Curley SA, Fornage BD et al. Radiofrequency ablation of hepatic metastases. Semin Oncol 2002;29:168-182.
9. Iannitti DA, Dupuy DE, Mayo-Smith WW et al. Hepatic radiofrequency ablation. Arch Surg 2002;137:422-427.
10. Berber E, Flesher N, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 2002;26:985-990.
11. Hellman P, Ladjevardi S, Skogseid B et al. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg 2002;26:1052-1056.
12. Seidenfeld J, Korn A, Aronson N. Radiofrequency ablation of unresectable liver metastases. J Am Coll Surg 2002;195:378-386.
13. Fong Y, Fortner J, Sun RL et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-321.
14. Jaeck D, Oussoultzoglou E, Rosso E et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004;240:1037-1051.
15. Machi J, Oishi AJ, Morioka WK et al. Radiofrequency thermal ablation of synchronous metastatic liver tumors can be performed safely in conjunction with colorectal cancer resection. Cancer J 2000;6[suppl 4]:S344-S350.
16. Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1998;103:278-288.
17. Scheele J, Stang R, Altendorf-Hofmann A et al. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
18. Nordlinger B, Guiguet M, Vaillant JC et al. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996;77:1254-1262.
19. Fernandez FG, Drebin JA, Linehan DC et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438-450.
20. Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-766.
21. Abdalla EK, Vauthey JN, Ellis LM et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-827.
22. Lencioni R, Goletti O, Armillotta N et al. Radio-frequency thermal ablation of liver metastases with cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998;8:1205-1211.
23. Solbiati L, Ierace T, Tonolini M et al. Long-term survival of patients treated with radiofrequency ablation for liver colorectal metastases: improved outcome with increasing experience. Radiology 2003;229:411.
24. Lencioni R, Crocetti L, Cioni D et al. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol 2004;39:689-697.
25. Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004;14:2261-2267.
26. De Baere TJ, Elias D, Ducreux M et al. Percutaneous radiofrequency of liver metastases: single center experience over a five year period [abstract 1387]. Proc Am Soc Clin Oncol 2003;22:345.
27. Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005;23:1358-1364.
28. Curley SA, Marra P, Beaty K et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004;239:450-458.
29. Grothey A, Sargent D, Goldberg RM et al. Survival of patients with advanced colorectal cancer improves with availability of fluorouracil- leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol 2004;22:1209-1214.
30. Hurwitz H, Fehrenbacher L, Novotny W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342.
31. Rougier P, Lepille D, Bennouna J et al. Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomized, multicentre phase II study. Ann Oncol 2002;13:1558-1567.
32. Pitot HC, Rowland KM, Sargent DJ et al. N9841: a randomized, phase III equivalence trial of irinotecan (CPT-11) versus oxaliplatin/5-fluorouracil (FU)/leucovorin (FOLFOX4) in patients with advanced colorectal cancer previously treated with 5FU [abstract 3506]. Proc ASCO 2005'.
33. Giantonio BJ, Catalano PJ, Meropol NJ. High-dose bevacizumab improves survival when combined with FOLFOX 4 in previously treated advanced colorectal cancer: results from ECOG study E3200 [abstract 2]. Proc ASCO 2005.
34. Pawlik TM, Izzo F, Cohen DS et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003;10:1059-1069.